2.83 0.01 (0.35%)

47.00% Fall from 52W High

587.0K XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Savara Inc is on 28 Mar 2025 for the purpose of Savara Inc Annual Report for 2024 See details

Savara Inc Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
-
Expensive Valuation
6.8 / 100
Technically Neutral
46.7 / 100

Savara Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Savara Inc Stock Analysis

Savara Inc stock analysis with key metrics, changes, and trends.

Savara Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$54.7 M11.86%negative

Annual Net Profit fell 11.86% in the last year to $54.7 M. Its sector's average net profit growth for the last fiscal year was -32.46%.

Price to Earning Ratio-5.86-negative

Price to Earning Ratio is -5.86, which is negative.

Stock Price$2.83-41.04%negative

Stock Price fell 41.04% and underperformed its sector by 50.94% in the past year.

Quarterly Net profit$24.25 M46.08%negative

Quarterly Net profit fell 46.08% YoY to $24.25 M. Its sector's average net profit growth YoY for the quarter was -47.25%.

Debt to Equity Ratio0.19-positive

Debt to Equity Ratio of 0.19 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-44.08 %-44.08%negative

Return on Equity(ROE) for the last financial year was -44.08%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding24.94 %-3.16%negative

Mutual Fund Holding decreased by 3.16% in the last quarter to 24.94.

Promoter Share Holding11.75 %1.43%positive

Promoter Share Holding increased by 1.43% in the most recent quarter to 11.75%.

Institutional Holding90.32 %1.39%positive

Institutional Holding increased by 1.39% in the last quarter to 90.32.

VIEW LESS


Loading data..

Savara Inc - Company Profile

What does Savara Inc do?

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara Inc Management structure

All Gross Remunerations are in USD
Mr. Braden C. Parker
Chief Commercial Officer
-
2025
Gross Remuneration
Year

Savara Inc Board of directors

All Gross Remunerations are in USD
Dr. Ricky L. Sun, PhD
Independent Director
-
2024
Gross Remuneration
Year

Savara Inc FAQ

How is Savara Inc today?
Savara Inc today is trading in the green, and is up by 0.35% at 2.83.
Savara Inc is currently trading up 0.35% on an intraday basis. In the past week the stock rose 8.43%. stock has been down -12.92% in the past quarter and fell -41.04% in the past year. You can view this in the overview section.